Adicet Bio, Inc. - ACET

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 17, 2026 SCHEDULE 13G Woodline Partners LP 6.5% 625,000 View
Feb 17, 2026 SCHEDULE 13G/A TANG CAPITAL MANAGEMENT, LLC 0.1% 6,158 View
Feb 17, 2026 SCHEDULE 13G/A KEVIN TANG 0.1% 6,158 View
Feb 17, 2026 SCHEDULE 13G/A TANG CAPITAL PARTNERS, LP 0.0% 0 View
Feb 17, 2026 SCHEDULE 13G/A TANG CAPITAL PARTNERS INTERNATIONAL, LP 0.1% 6,158 View
Feb 17, 2026 SCHEDULE 13G/A TANG CAPITAL PARTNERS III, INC 0.0% 0 View
Feb 17, 2026 SCHEDULE 13G/A TANG CAPITAL PARTNERS IV, INC 0.0% 0 View
Feb 17, 2026 SCHEDULE 13G/A RA Capital Management, L.P. 9.9% 960,237 View
Feb 17, 2026 SCHEDULE 13G/A Peter Kolchinsky 9.9% 960,237 View
Feb 17, 2026 SCHEDULE 13G/A Rajeev Shah 9.9% 960,237 View
Feb 17, 2026 SCHEDULE 13G/A RA Capital Healthcare Fund, L.P. 9.9% 960,237 View
Oct 10, 2025 SCHEDULE 13D/A 1.0% View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.